Explore Watchlists Pricing

NEUROCRINE BIOSCIENCES INC (NBIX) Balance sheet

Market cap

$12.8B

P/E ratio

27.3x

Summary Financials

Income statement Balance sheet Cash flow Other

	2011/12	2012/12	2013/12	2014/12	2015/12	2016/12	2017/12	2018/12	2019/12	2020/12	2021/12	2022/12	2023/12	2024/12	2025/12
Cash and cash equivalents	50	64	45	31	74	83	255	147	115	190	344	271	259	241	721
Total cash & short-term investments	50	64	45	31	74	83	255	147	115	190	344	271	259	241	721
Accounts receivable, net	-	-	-	-	-	-	31	56	127	157	186	350	-	479	687
Inventories	-	-	-	-	-	-	-	11	17	28	31	35	38	57	69
Total current assets	132	189	148	198	384	310	555	738	831	1,016	973	1,454	1,607	1,725	2,523
Property, plant and equipment, net	2	2	2	3	3	6	11	34	42	45	59	59	71	83	90
Marketable securities, non-current	-	0	-	37	82	43	247	216	300	227	561	299	688	740	1,063
Total assets	138	196	155	243	475	365	818	993	1,306	1,735	2,073	2,369	3,251	3,719	4,632
Accounts payable	1	1	0	0	3	5	-	-	-	-	-	-	-	-	-
Total current liabilities	47	16	12	16	26	30	54	88	565	187	246	538	655	508	743
Total liabilities	78	42	34	34	50	50	445	512	669	609	699	661	1,019	1,129	1,378
Retained earnings	-725	-720	-766	-826	-915	-1,056	-1,199	-1,178	-1,133	-725	-636	-407	-157	29	448
Stockholders' equity	60	154	120	209	424	315	372	481	637	1,126	1,374	1,708	2,232	2,590	3,253